News | April 08, 2026
Dabur reports steady domestic growth amid global headwinds in Q4 FY26
The India FMCG business showed a sequential recovery and is expected to post high-single digit growth
The India FMCG business showed a sequential recovery and is expected to post high-single digit growth
The new capital is expected to fund the company through 2029
Chronic GVHD is a serious and potentially life-threatening condition, imposing profound physical and emotional burdens on a substantial proportion of patients following allogeneic stem cell transplantation
Sharp increase in diabetes, hypertension and fatty liver in 30–50 age group
As demand for GLP-1 therapies explodes, India’s drug regulator moves to curb advertising amid rising concerns over misuse, access, and long-term impact
India’s first prospective study finds molecular testing improved diagnostic clarity in 50% of complex sarcoma cases
Analysis of over 93 lakh preventive health checkups reveals disease risks emerging as early as the 20s
They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market
The record-setting effort stems from Danone India’s nationwide ‘IRON UP!’ campaign
71-year-old high-risk patient with atrial fibrillation and ventricular tachycardia discharged next day
Subscribe To Our Newsletter & Stay Updated
